CoChat

The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis

Open access
Tenca, Andrea, Mustonen, Harri, Lind, Kati, Lantto, Eila, Kolho, Kaija‐Leena, Boyd, Sonja, Arola, Johanna, Jokelainen, Kalle, Färkkilä, Martti · 2018 · Liver International
Cited by 37

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Background & Aims: Endoscopic retrograde cholangiography (ERCP) has been considered the gold standard for the diagnosis and follow‐up of primary sclerosing cholangitis, but it has been replaced by less invasive magnetic resonance imaging and cholangiopancreatography (MRI‐MRCP). However, the role of these two techniques in the evaluation of disease activity and severity needs to be elucidated. Methods: Patients with primary sclerosing cholangitis (n: 48, male 31, median age: 35.7; 28.0‐44.2) who underwent ERCP and MRI‐MRCP within ±3 months for diagnosis or follow‐up, were reviewed. ERCP and MRI‐MRCP images were scored using the modified Amsterdam score. Serum and biliary cytology markers of disease activity and severity were related to the imaging findings. Agreement on the assessment of the ERCP/MRCP score was calculated by kappa‐statistics. Spearman′s ρ was calculated when appropriate. Results: The agreement between ERCP and MRCP in scoring bile duct changes for disease severity was only moderate (weighted kappa: 0.437; 95% CI: 0.211‐0.644 for intra‐ and 0.512; 95% CI: 0.303‐0.720 for extra‐hepatic bile ducts). ERCP and MRCP intra‐hepatic scores were associated to the surrogate marker alkaline phosphatase (P = .02 for both). A weak correlation between MRCP score for extra‐hepatic bile ducts and liver transplantation/death was found (Spearman's ρ = .362, 95% CI: 0.080‐0.590, P = .022). A weak correlation between intra‐ (Spearman′s ρ = .322, 95% CI: 0.048‐0.551, P = .022) and extra‐hepatic (Spearman`s ρ = .319, 95% CI: 0.045‐0.549, P = .025) peribiliary enhancement on contrast‐enhanced MRI and severity of biliary cytologic classification was found. Conclusions: The overall agreement between ERCP and MRI‐MRCP in assessing disease severity was moderate for intra‐ and extra‐hepatic bile ducts. MRI‐MRCP seems to have a minor role as surrogate marker of disease activity and progression in PSC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/liv.13899

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 37

Metadata

Authors
Tenca, A., Mustonen, H., Lind, K., Lantto, E., Kolho, K., Boyd, S., Arola, J., Jokelainen, K., & Färkkilä, M.
Venue
Liver International
Publisher
Wiley
Published
2018-07-18
Volume
38
Issue
12
Pages
2329-2339
ISSN
  • 0106-9543 (ISSN-L)
  • 1478-3223
  • 1478-3231
OpenAlex
W2808124587
Cited by
37
References
15
FWCI
1.73
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis. https://app.cochat.ai/papers/10.1111/liv.13899
The paper
Tenca, A., Mustonen, H., Lind, K., Lantto, E., Kolho, K., Boyd, S., Arola, J., Jokelainen, K., & Färkkilä, M. (2018). The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis. Liver International. https://doi.org/10.1111/liv.13899

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.